Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis
Magazine: European Journal of Pediatrics
Date: Mar 1, 1994Pediatrics [SP]
We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow transplant.
CITATION Eur J Pediatr. 1994 Mar;153(3):164-6
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.